Skip to main content
SpringerLink
Log in
Book cover

Immunotherapy and Biomarkers in Neurodegenerative Disorders

  • Book
  • © 2016

Overview

Editors:
  1. Martin Ingelsson

    1. Dept Public Health & Caring Sci Ger, Uppsala University, Uppsala, Sweden

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Lars Lannfelt

    1. Dept Public Health & Caring Sci Ger, Uppsala University, Uppsala, Sweden

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Includes cutting-edge techniques for the study of neurodegenerative disorders through immunotherapy and biomarker research
  • Offers state-of-the-art contributions from renowned experts
  • Features practical and vital implementation advice
  • Includes supplementary material: sn.pub/extras

Part of the book series: Methods in Pharmacology and Toxicology (MIPT)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 protocols)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Immunotherapy Against Amyloid-β in Alzheimer’s Disease

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Immunotherapy Against Amyloid-β in Alzheimer’s Disease: An Overview

      • Niels D. Prins
      Pages 3-17

    3. Active Immunization Against the Amyloid-β Peptide

      • Enchi Liu, J. Michael Ryan
      Pages 19-35

    4. Immunotherapy Against N-Truncated Amyloid-β Oligomers

      • Thomas A. Bayer, Oliver Wirths
      Pages 37-50

    5. Immunotherapy Against Amyloid-β Protofibrils: Opportunities and Challenges

      • Lars Lannfelt
      Pages 51-60

  3. Immunotherapy in Other Neurodegenerative Disorders

    1. Front Matter

      Pages 61-61
      Download chapter PDF

    2. Immunotherapy Against α-Synuclein Pathology

      • Elvira Valera, Eliezer Masliah
      Pages 63-72

    3. Extracellular α-Synuclein as a Target for Immunotherapy

      • Jun Sung Lee, Seung-Jae Lee
      Pages 73-83

    4. Immunotherapy of Parkinson’s Disease

      • Achim Schneeberger, Suzanne Hendrix, Markus Mandler
      Pages 85-108

    5. Tau Immunotherapy

      • Einar M. Sigurdsson
      Pages 109-120

    6. Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms

      • Kiran Yanamandra, Marc I. Diamond, David M. Holtzman
      Pages 121-138

    7. Immunotherapy on Experimental Models for Huntington’s Disease

      • Anne Messer
      Pages 139-150

  4. Biomarkers for Neurodegenerative Disorders

    1. Front Matter

      Pages 151-151
      Download chapter PDF

    2. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

      • Henrik Zetterberg, Jonathan M. Schott
      Pages 153-179

    3. Volumetric MRI as a Diagnostic Tool in Alzheimer’s Disease

      • Eric Westman, Lena Cavalin, Lars-Olof Wahlund
      Pages 181-198

    4. PET Imaging as a Diagnostic Tool in Alzheimer’s Disease

      • Juha O. Rinne
      Pages 199-213

    5. Alpha-Synuclein as a Diagnostic Biomarker for Parkinson’s Disease

      • Joakim Bergström, Martin Ingelsson
      Pages 215-234

    6. Imaging as a Diagnostic Tool in Parkinson’s Disease

      • Johan Wikström, Torsten Danfors
      Pages 235-252

    7. Mass Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative Diseases

      • Sravani Musunuri, Ganna Shevchenko, Jonas Bergquist
      Pages 253-282
Back to top

Keywords

About this book

This practical volume examines a number of topics that explore the current status of immunotherapy and diagnostic markers for neurodegenerative disorders. With a focus on Alzheimer’s disease, the first sections of the book examine immunotherapeutic approaches for the aforementioned disease as well as for Parkinson’s disease and Huntington’s disease, amongst others. The last section of the book covers the importance of biomarker techniques to catch these diseases early enough for the treatments to be most useful. Written for the Methods in Pharmacology and Toxicology series, this book contains the kind of detailed descriptions and implementation advice that will offer a smooth transition into the lab.

Authoritative and useful, Immunotherapy and Biomarkers in Neurodegenerative Disorders aims to aid in the continued progress in the development of novel immune-based drugs and diagnostic tools for these devastating brain diseases.

Editors and Affiliations

  • Dept Public Health & Caring Sci Ger, Uppsala University, Uppsala, Sweden

    Martin Ingelsson, Lars Lannfelt

Bibliographic Information

  • Book Title: Immunotherapy and Biomarkers in Neurodegenerative Disorders

  • Editors: Martin Ingelsson, Lars Lannfelt

  • Series Title: Methods in Pharmacology and Toxicology

  • DOI: https://doi.org/10.1007/978-1-4939-3560-4

  • Publisher: Humana New York, NY

  • eBook Packages: Springer Protocols

  • Copyright Information: Springer Science+Business Media New York 2016

  • Hardcover ISBN: 978-1-4939-3558-1Published: 14 April 2016

  • Softcover ISBN: 978-1-4939-8078-9Published: 19 April 2018

  • eBook ISBN: 978-1-4939-3560-4Published: 13 April 2016

  • Series ISSN: 1557-2153

  • Series E-ISSN: 1940-6053

  • Edition Number: 1

  • Number of Pages: X, 289

  • Number of Illustrations: 8 b/w illustrations, 32 illustrations in colour

  • Topics: Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation